BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P10
Near historical low
vs 5Y Ago
-0.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.90% |
| Q3 2025 | -5.82% |
| Q2 2025 | 13.77% |
| Q1 2025 | -2.88% |
| Q4 2024 | 9.67% |
| Q3 2024 | -4.18% |
| Q2 2024 | 11.06% |
| Q1 2024 | 2.53% |
| Q4 2023 | 12.67% |
| Q3 2023 | -2.45% |
| Q2 2023 | 0.81% |
| Q1 2023 | 12.36% |
| Q4 2022 | 5.45% |
| Q3 2022 | -5.26% |
| Q2 2022 | 2.06% |
| Q1 2022 | 21.92% |
| Q4 2021 | 8.14% |
| Q3 2021 | -18.53% |
| Q2 2021 | 2.40% |
| Q1 2021 | 12.23% |
| Q4 2020 | 13.19% |
| Q3 2020 | -13.13% |
| Q2 2020 | -15.14% |
| Q1 2020 | 8.96% |
| Q4 2019 | -1.54% |
| Q3 2019 | 17.34% |
| Q2 2019 | -0.40% |
| Q1 2019 | 11.99% |
| Q4 2018 | -11.07% |
| Q3 2018 | 6.46% |
| Q2 2018 | 0.93% |
| Q1 2018 | 3.12% |
| Q4 2017 | 2.78% |
| Q3 2017 | 5.18% |
| Q2 2017 | 2.92% |
| Q1 2017 | 7.54% |
| Q4 2016 | 2.96% |
| Q3 2016 | -7.79% |
| Q2 2016 | 28.35% |
| Q1 2016 | 4.47% |